From medical B2B sales to jewelry stores, smart rings may find new avenues to attracting consumer interest beyond the niche ...

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought ...

The soon-to-be 47th president is succeeding at just about every enterprise he undertakes, while his political and ideological ...

The demand for efficiency in trade processes has never been greater. Traditional methods of trade documentation, heavily ...

President-elect Donald Trump will hold a rally in Washington on Sunday, one day before his inauguration inside the Capitol ...

On this "Face the Nation with Margaret Brennan" broadcast, incoming National Security Adviser Mike Waltz, and Middle East ...

Trump secured the reelection of House Speaker Mike Johnson (R-La.) in the narrowly divided House by limiting Republicans' ...

Plus, $117 million in NTIA grants go out, Indiana funds county broadband expansion, the E-BRIDGE Act is now the law of the ...

The stock price of Zydus Lifesciences surged over 5 per cent in the Tuesday trading session after the drugmaker’s wholly ...

Former Wisconsin cornerback Xavier Lucas circumvented the transfer portal and potentially created a new path for athletes ...

VET3-T12 is under clinical development by KaliVir Immunotherapeutics and currently in Phase I for Sarcomas. According to GlobalData, Phase I drugs for Sarcomas have a 77% phase transition success rate ...

Wisconsin refused to enter Lucas into the portal after he requested a transfer, but he's off to Miami regardless in a ...